Study types
- article 6
Condition tags
- endometriosis 3
- infertility 1
- adenomyosis 1
Top journals
Frequent coauthors
- Yingying Zhang 3
- Canquan Zhou 2
- Lu Luo 2
- Can Wang 1
- Haitao Wu 1
- Jun Gao 1
- Er-min Gu 1
- Jin Li 1
- Jian-xin Lao 1
- Chaojie Chen 1
article
2025
STUDY QUESTION: What are the unrecognized risk factors for recurrent implantation failure (RIF) as defined in the ESHRE recommendation? SUMMARY ANSWER: Anti-Müllerian hormone (AMH) is the strongest predictor for RIF, followed by chronic en…
article
2021
Elagolix, as a competitive gonadotropin-releasing hormone (GnRH) receptor antagonist, has been recently approved by the US FDA for the management of moderate to severe pain due to endometriosis in women. In this study, we developed and veri…
article
2020
Introduction:Although pre-treatment with a GnRH agonist can reduce the size of adenomyosis lesions, the supra-physiological hormone level induced by controlled ovarian hyperstimulation (COH) may negate the usefulness of the GnRH agonist in …
article
2019
PURPOSE: To investigate the expression and relevant clinical and pathological significance of AT-rich interactive domaincontaining protein 1A (ARID1A) mRNA in endometriosis-associated ovarian cancer. METHODS: The clinical and pathological d…
article
2012
BACKGROUND: The aim of the study was to determine the efficacy of in vitro fertilization and embryo transfer (IVF-ET) in patients with hyper-response to ovulation induction for intrauterine insemination (IUI). METHODS: Patients with polycys…
article
2010
OBJECTIVE: To evaluate the effect of epidural anesthesia and patient-controlled epidural analgesia (PCEA) on hemorheology and the incidence of deep venous thrombosis in patients undergoing gynecological laparoscopy. METHODS: One hundred ASA…